This is the authors' abstract. We don't add key points for this paper.
High Resolution Image Download MS PowerPoint Slide A D–A−π–A dye ( PTZ-5 ) has been synthesized by introducing a benzothiadiazole (BTD) unit as an auxiliary acceptor in a phenothiazine-based D−π–A dye( PTZ-3 ) to broaden its spectral response range and improve the device performance. Photophysical properties indicate that the inclusion of BTD in the PTZ-5 effectively red-shifted the absorption spectra by reducing the E gap . However, the device measurements show that the open-circuit voltage ( V oc ) of PTZ-5 cell (640 mV) is obviously lower than that of the PTZ-3 cell (710 mV). This results in a poor photoelectric conversion efficiency (PCE) (4.43%) compared to that of PTZ-3 cell (5.53%). Through further comparative analysis, we found that the introduction of BTD increases the dihedral angle between the D and A unit, which can reduce the efficiency of intramolecular charge transfer (ICT), lead to a less q CT and lower molar extinction coefficient of PTZ-5 . In addition, the ESI test found that the lifetime of the electrons in the PTZ-5 cell is shorter. These are the main factors for the above unexpected result of PCE. Our studies bring new insights into the development of phenothiazine-based highly efficient dye-sensitized solar cells (DSSCs).
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: